entertainment -WSS

entertainment

author：knowledge 2025-08-28 13:05:52 - browse：43

A group of four doctors gather around a hologram projecting different medical icons — health tech coverage from STAT — Adobe

DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental health company Twill for $10 million in cash plus stock valued at over $20 million at the end of Tuesday trading. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.

Founded in 2011, Dario started with a diabetes app targeted at consumers before expanding it to hypertension and weight management. It still maintains that direct-to-consumer business but has since shifted its focus to selling its suite of offerings, including a musculoskeletal care program it acquired in 2021, to health plans and employers in the hopes of reaching much larger patient populations. Recent updates aimed at making itself attractive to clients include a new offering built around popular, and expensive, GLP-1 weight loss drugs, and published real world data suggesting its tools can save clients money on downstream health care costs. With Twill, Dario adds a mental health app and related services, addressing a top demand of employers.

Despite momentum, DarioHealth, which is publicly traded, is unprofitable, and by its own estimations on earnings calls last year, it remained a ways from that milestone. Before acquiring Twill, the company said that it expected the whole business to break even at about $80 million in revenue — about four times the roughly $20 million it projected for 2023. In November, the company reported that it lost over $40 million in the first nine months of 2023.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Health tech investors get more selective as pandemic boom fades

leisure time

entertainment

WSS

Does good food count as health care? Study aims to find out

STAT Summit: Meghan O’Rourke on making chronic illness visible

FDA clears Verve to begin U.S. study of gene

UnitedHealth, Optum discontinue NaviHealth name

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

David Sabatini, ex

explore

entertainment

explore

Cancer drug shortages should be causing more outrage

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

State Dept. review finds Biden bears some blame for Afghanistan failures

STAT Summit: Ending the crisis of Black deaths in the U.S.

Jerome Adams on the need for new antivirals for Covid

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Virginia high school admissions case could be legal follow

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Alkermes shareholders re

UnitedHealth, Optum discontinue NaviHealth name

focus

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

CRISPR pioneers react to Casgevy, first gene

UnitedHealth, Optum discontinue NaviHealth name

CRISPR pioneers react to Casgevy, first gene

Anthos stroke drug appears safer than common blood thinner

FDA clears Verve to begin U.S. study of gene

hotspot

leisure time

entertainment

focus